Efficacy of prolonged-release fampridine versus placebo on walking ability, dynamic and static balance, physical impact of multiple sclerosis, and quality of life: an integrated analysis of MOBILE and ENHANCE.
- DOI
- 10.1177/17562864221090398
- Published
- 2022
- Container
- Therapeutic advances in neurological disorders
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/17562864221090398,
title = {Efficacy of prolonged-release fampridine versus placebo on walking ability, dynamic and static balance, physical impact of multiple sclerosis, and quality of life: an integrated analysis of MOBILE and ENHANCE.},
author = {Hupperts R and Gasperini C and Lycke J and Ziemssen T and Feys P and Xiao S and Acosta C and Koster T and Hobart J},
year = {2022},
journal = {Therapeutic advances in neurological disorders},
doi = {10.1177/17562864221090398},
url = {https://doi.org/10.1177/17562864221090398}
}RIS
TY - JOUR TI - Efficacy of prolonged-release fampridine versus placebo on walking ability, dynamic and static balance, physical impact of multiple sclerosis, and quality of life: an integrated analysis of MOBILE and ENHANCE. AU - Hupperts R AU - Gasperini C AU - Lycke J AU - Ziemssen T AU - Feys P AU - Xiao S AU - Acosta C AU - Koster T AU - Hobart J PY - 2022 JO - Therapeutic advances in neurological disorders DO - 10.1177/17562864221090398 UR - https://doi.org/10.1177/17562864221090398 ER -
APA
R, H., C, G., J, L., T, Z., P, F., S, X., C, A., T, K., & J, H. (2022). Efficacy of prolonged-release fampridine versus placebo on walking ability, dynamic and static balance, physical impact of multiple sclerosis, and quality of life: an integrated analysis of MOBILE and ENHANCE.. Therapeutic advances in neurological disorders. https://doi.org/10.1177/17562864221090398
Source records
- pubmed · retrieved 2026-09-26T18:20:20.579Z